83 related articles for article (PubMed ID: 6778990)
1. Dose-dependent pharmacokinetics of tocainide in the rat.
Venkataramanan R; Axelson JE
J Pharmacol Exp Ther; 1980 Oct; 215(1):231-4. PubMed ID: 6778990
[TBL] [Abstract][Full Text] [Related]
2. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
Venkataramanan R; Axelson JE
J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
[TBL] [Abstract][Full Text] [Related]
3. Disposition of (R,S)-tocainide. Some stereoselective aspects.
Gal J; French TA; Zysset T; Haroldsen PE
Drug Metab Dispos; 1982; 10(4):399-404. PubMed ID: 6126341
[TBL] [Abstract][Full Text] [Related]
4. Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase.
Elvin AT; Lalka D; Stoeckel K; du Souich P; Axelson JE; Golden LH; McLean AJ
Clin Pharmacol Ther; 1980 Nov; 28(5):652-8. PubMed ID: 6777107
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of tocainide in the rat.
Venkataramanan R; Abbott FS; Axelson JE
J Pharm Sci; 1982 May; 71(5):491-4. PubMed ID: 6808112
[TBL] [Abstract][Full Text] [Related]
6. Influence of rifampin on tocainide pharmacokinetics in humans.
Rice TL; Patterson JH; Celestin C; Foster JR; Powell JR
Clin Pharm; 1989 Mar; 8(3):200-5. PubMed ID: 2495879
[TBL] [Abstract][Full Text] [Related]
7. Tocainide conjugation in humans: novel biotransformation pathway for a primary amine.
Elvin AT; Keenaghan JB; Byrnes EW; Tenthorey PA; McMaster PD; Takman BH; Lalka D; Manion CV; Baer DT; Wolshin EM; Meyer MB; Ronfeld RA
J Pharm Sci; 1980 Jan; 69(1):47-9. PubMed ID: 7354440
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tocainide in acute myocardial ischaemia.
Sutton PP
Br J Clin Pharmacol; 1980 Nov; 10(5):530-1. PubMed ID: 6776976
[No Abstract] [Full Text] [Related]
9. Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: involvement of enzyme inactivation.
Lin JH; Chen IW; Chiba M; Nishime JA; Deluna FA
Drug Metab Dispos; 2000 Apr; 28(4):460-6. PubMed ID: 10725315
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
[TBL] [Abstract][Full Text] [Related]
11. Excretion and metabolism of DA-7867, a new oxazolidinone, in rats.
Bae SK; Kim EJ; Kwon JW; Kim WB; Lee I; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):67-75. PubMed ID: 15617136
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
Drug Metab Dispos; 1996 Aug; 24(8):911-21. PubMed ID: 8869828
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
15. Acute dose-dependent disposition studies of nicotinic acid in rats.
Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
Dunnick J
Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study.
Tsai PL; Tsai TH
Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664
[TBL] [Abstract][Full Text] [Related]
18. A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
Kwok DW; McErlane KM; Axelson JE
Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):395-409. PubMed ID: 2111573
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
